CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 11 No. 2
Pages: 1  2  
Next
 

NCI Releases Report on Nation’s Progress Against Cancer

February 1, 2002

BETHESDA, Maryland—The National Cancer Institute’s Cancer Progress Report 2001—a living document that the Institute will update once or twice a year online and every few years in printed form—renders a mixed judgment about the nation’s success in reducing the burden of cancer.

"This is a report that basically tells us how we are doing as a nation," said Robert A. Hiatt, MD, PhD, deputy director of NCI’s Division of Cancer Control and Population Sciences (DCCPS) and chair of the committee that assembled the report. "The main message is a positive one. The nation is making good progress against cancer, but trends in some areas are going in the wrong direction."

On the plus side, the report said:

  • The rates of both new cancer cases and cancer deaths are falling overall.
  • Some prevention behaviors have shown improvement. Adult smoking is down dramatically since the 1960s, although rates fell only slightly in the 1990s. Consumption of alcohol(Drug information on alcohol) and fat is headed down, while fruit and vegetable consumption is up.
  • The use of screening tests for breast, cervical, and colorectal cancers is increasing, although screening rates for colorectal cancer remain low.

In the minus column:

  • Some cancers are rising dramatically, such as cancer of the esophagus and melanoma. Lung cancer in women continues to rise but not as rapidly as before.
  • Youth smoking has been on the rise, although data show there may be a recent, promising decline.
  • People are doing less to protect themselves from the sun.
  • More people are overweight or obese, and physical activity is increasing only slightly.
  • Cancer treatment spending continues to rise along with total health care spending.
  • Unexplained cancer-related health disparities remain among population subgroups. Blacks and people with low socioeconomic status, for example, have the highest overall rates for both new cancers and deaths.

The data were gathered through a collaboration with other organizations, including the Centers for Disease Control and Prevention, other federal health agencies, the American Cancer Society, professional groups, and cancer researchers.

The report tracks progress in prevention, early detection, diagnosis, life after cancer, and end of life, and where possible, compares the status of each with the goals of Healthy People 2010, a set of 10-year objectives established by the Department of Health and Human Services.

Using color-coded graphics, Cancer Progress 2001 shows which trends are rising and which are falling. For example, in the Highlights’ prevention section, the report notes a positive trend in smoking reduction among Americans ages 18 and older. The percentage of adults smoking cigarettes dropped to 24% in 1998 from 26% in 1992, with the target goal in 2010 set at 12%. Youth smoking showed a negative trend, rising from 28% in 1991 to 35% in 1999, with the 2010 goal set at 16%. More recent data, however, suggest a reversal of this trend.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy